HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaofei Wang Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

4/2024Availability of genome-matched therapy based on clinical practice.
1/2023The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin.
3/2021Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer.
1/2021Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy.
4/2020Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis.
1/2020Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaofei Wang Research Topics

Disease

174Neoplasms (Cancer)
05/2024 - 09/2004
53Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 12/2006
29Neoplasm Metastasis (Metastasis)
01/2023 - 03/2010
22Stomach Neoplasms (Stomach Cancer)
01/2023 - 07/2015
21Lung Neoplasms (Lung Cancer)
11/2023 - 02/2008
20Leukemia
10/2019 - 01/2007
18Hepatocellular Carcinoma (Hepatoma)
03/2024 - 11/2012
17Carcinogenesis
05/2024 - 08/2010
16Inflammation (Inflammations)
01/2024 - 11/2007
14Breast Neoplasms (Breast Cancer)
05/2024 - 05/2010
14Carcinoma (Carcinomatosis)
11/2022 - 06/2005
12Infections
05/2024 - 07/2007
11Thyroid Neoplasms (Thyroid Cancer)
01/2024 - 04/2016
10Hypoxia (Hypoxemia)
02/2024 - 09/2004
10Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2023 - 02/2008
9Obesity
04/2024 - 02/2004
9Rheumatoid Arthritis
12/2023 - 10/2004
9Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2014
8Sarcoma (Soft Tissue Sarcoma)
04/2024 - 01/2021
8Necrosis
01/2024 - 04/2005
8Disease Progression
06/2022 - 10/2019
8Atherosclerosis
11/2020 - 06/2002
7Liver Neoplasms (Liver Cancer)
10/2023 - 02/2011
7Intervertebral Disc Degeneration
07/2021 - 06/2016
7Adenocarcinoma
07/2021 - 12/2006
6Head and Neck Neoplasms (Head and Neck Cancer)
04/2024 - 01/2020
6Insulin Resistance
03/2024 - 02/2004
6Fibrosis (Cirrhosis)
02/2024 - 01/2011
6Colorectal Neoplasms (Colorectal Cancer)
05/2023 - 11/2016
6Adenocarcinoma of Lung
01/2023 - 06/2012
6Spinal Cord Injuries (Spinal Cord Injury)
02/2015 - 05/2007
5Neuromyelitis Optica (Devic's Disease)
05/2024 - 01/2022
5Thrombosis (Thrombus)
04/2024 - 11/2017
5Prostatic Neoplasms (Prostate Cancer)
02/2024 - 06/2005
5Ischemia
02/2024 - 04/2005
5Malignant Mesothelioma
11/2023 - 10/2010
5Autoimmune Diseases (Autoimmune Disease)
10/2023 - 02/2010
5Acute Lung Injury
02/2023 - 12/2013
5Fatigue
01/2023 - 09/2011
5Melanoma (Melanoma, Malignant)
12/2022 - 08/2010
5Hypertension (High Blood Pressure)
09/2022 - 06/2012
5Wounds and Injuries (Trauma)
05/2022 - 01/2014
5Reperfusion Injury
01/2021 - 10/2005
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 12/2006
5Stroke (Strokes)
01/2019 - 02/2005
4COVID-19
04/2024 - 02/2021
4Neurodegenerative Diseases (Neurodegenerative Disease)
04/2024 - 02/2005
4Heart Failure
02/2024 - 11/2015

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
04/2024 - 12/2006
35Biomarkers (Surrogate Marker)IBA
05/2024 - 06/2010
20MicroRNAs (MicroRNA)IBA
01/2022 - 06/2014
17Messenger RNA (mRNA)IBA
12/2023 - 03/2010
14Carboplatin (JM8)FDA LinkGeneric
01/2023 - 01/2007
12RNA (Ribonucleic Acid)IBA
04/2024 - 01/2016
11Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 01/2007
10LipidsIBA
04/2024 - 02/2004
10ErbB Receptors (EGF Receptor)IBA
11/2023 - 12/2006
10CytokinesIBA
01/2023 - 11/2007
10Matrix Metalloproteinases (MMPs)IBA
01/2020 - 10/2004
9Glucose (Dextrose)FDA LinkGeneric
03/2024 - 02/2004
9LigandsIBA
01/2023 - 06/2014
8PlatinumIBA
11/2020 - 07/2013
7Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 06/2005
7Tyrosine Kinase InhibitorsIBA
11/2023 - 09/2004
7CateninsIBA
04/2023 - 01/2017
7Cadherins (E-Cadherin)IBA
10/2021 - 03/2015
7Small Interfering RNA (siRNA)IBA
04/2021 - 08/2010
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 12/2006
7Estrogens (Estrogen)FDA Link
01/2009 - 05/2003
6lenvatinibIBA
01/2024 - 03/2020
6DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2012
6Therapeutic UsesIBA
07/2023 - 02/2010
6Immune Checkpoint InhibitorsIBA
01/2023 - 06/2019
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 09/2004
6Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 03/2010
6Peptides (Polypeptides)IBA
06/2020 - 01/2015
5Fatty Acids (Saturated Fatty Acids)IBA
02/2024 - 12/2018
5IodineIBA
10/2023 - 01/2020
5CholesterolIBA
10/2023 - 02/2004
5LipopolysaccharidesIBA
02/2023 - 11/2013
5Interleukin-6 (Interleukin 6)IBA
01/2023 - 03/2008
5AlbuminsIBA
01/2023 - 01/2018
5EnzymesIBA
09/2021 - 01/2014
5Hematoxylin (Haematoxylon)IBA
07/2021 - 04/2013
5Eosine Yellowish-(YS) (Eosin)IBA
07/2021 - 04/2013
5Hormones (Hormone)IBA
01/2021 - 02/2005
5Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2019 - 06/2012
5Celecoxib (Celebrex)FDA Link
10/2019 - 12/2006
5Nylons (Nylon)IBA
04/2015 - 03/2010
4Apolipoproteins E (ApoE)IBA
05/2024 - 11/2008

Therapy/Procedure

64Therapeutics
05/2024 - 02/2004
43Drug Therapy (Chemotherapy)
06/2023 - 01/2007
25Radiotherapy
10/2023 - 12/2006
13Immunotherapy
02/2024 - 01/2020
8Chemoradiotherapy
01/2023 - 05/2010
7Adjuvant Chemotherapy
04/2024 - 05/2010
7Neoadjuvant Therapy
09/2023 - 12/2006
7Induction Chemotherapy
10/2022 - 05/2008
6Radiofrequency Ablation
10/2021 - 07/2017
5Lasers (Laser)
01/2022 - 07/2015